SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: ACAN who wrote (2232)6/15/2003 4:35:48 AM
From: Crossy  Read Replies (1) | Respond to of 23958
 
re: CTE
Stra10, Godot - I would second this pick. The merger it conducted early this year was a strategic genius move. Company already has revenues and will become profitable soon. Buyout certainly possible too. All the medeq companies I once had in my portfolio became gobbled up ultimately - both by Tyco - but there are other suitors as well (I had US Surgical and another stent maker years ago)

rgrds
CROSSY



To: ACAN who wrote (2232)6/15/2003 11:31:46 AM
From: Sergio H  Read Replies (2) | Respond to of 23958
 
CTE ADDED TO FOLIO @ Monday's opening price.

Hi Allan. Thanks for the briefing. Excellent pick. I like their game plan to establish a market for synthetic bypass grafts.

I read that there is only one other potential competitor but couldn't find who it is. Perhaps you or Crossy know?

Sergio


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News